一覧に戻る

タイトル
  • en Two cases of melanomas paradoxically metastasizing to the intestinal tract during nivolumab therapy
その他のタイトル
  • en Intestinal metastasis in melanoma
作成者
アクセス権 open access
権利情報
  • en This is the peer reviewed version of the following article: Miyazawa, H., Yanagi, T., Yamaguchi, Y., Imafuku, K., Kitamura, S., Hata, H., Uehara, J., Ichikawa, N., Ohno, Y., Yoshida, T., Homma, S., Kawamura, H., Taketomi, A. and Shimizu, H. (2017), Two cases of melanomas paradoxically metastasizing to the intestinal tract during nivolumab therapy. J Dermatol, 44: 959-962., which has been published in final form at https://doi.org/10.1111/1346-8138.13825. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
主題
  • Other en fecal occult blood test
  • Other en intestinal metastasis
  • Other en malignant melanoma
  • Other en nivolumab
  • Other en weight loss
  • NDC 490
内容注記
  • Abstract en We report two cases of melanomas in patients who developed intestinal metastasis despite other metastatic sites responding to nivolumab and despite the patients having favorable findings such as vitiligo and normal lactate dehydrogenase. The first case is an 85-year-old man who had been administrated nivolumab for lung/cutaneous metastases. After 22 courses of nivolumab therapy, fever and anorexia had appeared and his bodyweight had decreased. An intussusception on the ileocecal valve was revealed by computed tomography, and emergency surgery revealed metastatic lesions on the colon. The second case is an 87-year-old woman treated with nivolumab for lymph node metastases. After 10 courses, laboratory tests had revealed anemia and positive fecal occult blood. Her bodyweight had decreased. Capsule endoscopy showed scattered tumors and clots, indicating metastases of melanoma. The frequency of symptomatic intestinal metastasis of melanoma is very low. Further, intestinal metastasis of melanoma is difficult to detect through routine examinations. Our cases suggest that fecal occult blood test and decreased bodyweight are indications of intestinal metastases.
出版者 en John Wiley & Sons
日付
    Issued2017-08
言語
  • eng
資源タイプ journal article
出版タイプ AM
資源識別子 HDL http://hdl.handle.net/2115/71133
関連
  • isVersionOf DOI https://doi.org/10.1111/1346-8138.13825
  • PMID 28295515
収録誌情報
    • PISSN 0385-2407
      • en Journal of dermatology
      • 44 8 開始ページ959 終了ページ962
ファイル
コンテンツ更新日時 2023-07-26